The association of haemophilic arthropathy with Health‐Related Quality of Life: a post hoc analysis-Reference-Cited by-同舟云学术

The association of haemophilic arthropathy with Health‐Related Quality of Life: a post hoc analysis

Published:2016-10-26 Issue:6 Volume:22 Page:833-840
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Fischer K.¹,Kleijn P.¹,Negrier C.²³,Mauser‐Bunschoten E. P.¹,Valk P. R.¹,Galen K. P. M.¹,Willemze A.¹,Schutgens R.¹

Affiliation:

1. Van Creveldkliniek University Medical Center Utrecht Utrecht the Netherlands

2. Department of Rehabilitation Nursing Science and Sports University Medical Center Utrecht Utrecht the Netherlands

3. Unité d'Hémostase Clinique Center Régional de traitement de l'Hémophilie Lyon France

Funder

Bayer AG

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.13120

Reference41 articles.

1. Haemophilia in Sweden VII. Incidence, treatment and prophylaxis of arthropathy and other musculo‐skeletal manifestations of haemophilia A and B;Ahlberg A;Acta Orthop Scand,1965

2. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B

3. Treatment of haemophilia A and B and von Willebrand’s disease: summary and conclusions of a systematic review as part of a Swedish health-technology assessment

4. Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s

5. Purchasing factor concentrates in the 21st century through competitive tendering

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of joint health in patients receiving prophylaxis for haemophilia A: a cross-sectional survey in five European countries;BMJ Open;2024-09

2. Joint health and pain in the changing hemophilia treatment landscape;Expert Review of Hematology;2024-07-15

3. Real-world usage and effectiveness of recombinant factor VIII/factor IX Fc in hemophilia A/B: final data from the 24-month, prospective, noninterventional PREVENT study in Germany;Research and Practice in Thrombosis and Haemostasis;2024-07

4. The relevance of MRI findings in joints of persons with haemophilia: Insights from the last decade;Haemophilia;2024-05-29

5. Hämophilie-Behandlung in Österreich;Wiener klinische Wochenschrift;2024-05